Tag School of Pharmacy
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer
A team of UW–Madison scientists have uncovered that bile acids produced by the liver to help digest food may affect our risk for developing colon cancer.
UW–Madison leading new research collaboration aimed at treating lung scarring diseases
An interdisciplinary group of researchers will will investigate the biological processes that promote lung scarring. With the aid of artificial intelligence and advanced 3D modeling, they will also develop and refine new imaging techniques and drug delivery systems that could aid in halting its progression.
Pancreatic cancer is difficult to treat. Nano-drugs hitching a ride on bacteria could help.
Mice treated with the therapeutic-laden bacteria experienced delayed tumor growth and significantly longer survival compared with mice that received other treatments.
Nanomaterial that mimics proteins could be basis for new neurodegenerative disease treatments
The work centers around altering the interaction between two proteins that are believed to be involved in setting the stage for diseases like Alzheimer's, Parkinson's and amyotrophic lateral sclerosis, or ALS.
UW–Madison launches PharmD Early Assurance, opening door for more Wisconsin pharmacists
The PharmD Early Assurance program provides conditional admission to the UW–Madison Doctor of Pharmacy (PharmD) program for high school seniors who want to become a pharmacist and are admitted to a four-year UW System university.
New maps show antimicrobial resistance varies within Wisconsin neighborhoods
Mapping variations in antibiotic resistance could help patients receive better informed treatment decisions from their health care providers.
Health care on the home front: UW grads remain in the state to keep Wisconsin well
Doctors, nurses and pharmacists educated and trained in the UW’s health sciences programs are working in every one of the state’s 72 counties.
First-in-kind psychedelic trials treat opioid and methamphetamine use disorders
School of Pharmacy and School of Medicine and Public Health collaborators are leading two first-in-kind clinical psilocybin trials for treating opioid and methamphetamine use disorders.
Nonprescription CBD product labeling largely inaccurate, study finds
UW–Madison School of Pharmacy students concluded that just 15% of CBD-infused oil, beverages and other products are labeled correctly, based on a survey of stores in Southwestern Wisconsin.
School of Pharmacy announces master’s program scholarships to address inequities
These scholarships will be awarded to students pursuing a master’s degree in Pharmaceutical Sciences: Applied Drug Development or Psychoactive Pharmaceutical Investigation who demonstrate a financial need and/or have a strong commitment to diversity, equity and inclusion.
UW School of Pharmacy focused on equitable COVID-19 vaccine access
In partnership with the Boys and Girls Club of Dane County, students and employees of the School of Pharmacy are helping sponsor vaccine clinics and town hall discussions to address vaccine hesitancy and concerns.